Lipodystrophy at the insulin injection sites: current trends in epidemiology, diagnostics and prevention
Lipodystrophy at the injection sites is most common local complication of insulin therapy. The history of its study started in 1926, when first cases of lipoatrophy at the sites of insulin injections were described. As we moved to human insulin and insulin analogues, immune mediated atrophic form of...
Guardado en:
Autores principales: | Vadim V. Klimontov, Mikhail M. Lazarev, Andrey Ju. Letyagin, Dinara M. Bulumbaeva, Natalia P. Bgatova |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7fe9a1c09a59476c8fa484167227118d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Insulin-induced lipohypertrophy: clinical and ultrasound characteristics
por: Vadim V. Klimontov, et al.
Publicado: (2018) -
Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges
por: Chiquette E, et al.
Publicado: (2017) -
Familial Partial Lipodystrophy (FPLD): Recent Insights
por: Bagias C, et al.
Publicado: (2020) -
Prevalence, Risk Factors, and Clinical Characteristics of Lipodystrophy in Insulin-Treated Patients with Diabetes: An Old Problem in a New Era of Modern Insulin
por: Thewjitcharoen Y, et al.
Publicado: (2020) -
Lipodistrofias primarias: presentación clínica y diagnóstico
por: CORTÉS,VÍCTOR, et al.
Publicado: (2019)